ID: ALA4085161

Max Phase: Preclinical

Molecular Formula: C24H42N4O

Molecular Weight: 402.63

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCc1nc(N2CCC2)nc(N2CCC2)c1O

Standard InChI:  InChI=1S/C24H42N4O/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-21-22(29)23(27-17-14-18-27)26-24(25-21)28-19-15-20-28/h29H,2-20H2,1H3

Standard InChI Key:  CICRLEHVHJXVTD-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 402.63Molecular Weight (Monoisotopic): 402.3359AlogP: 5.85#Rotatable Bonds: 15
Polar Surface Area: 52.49Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.64CX Basic pKa: 7.45CX LogP: 7.18CX LogD: 6.86
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.37Np Likeness Score: -0.48

References

1. Chevalier A, Khdour OM, Schmierer M, Bandyopadhyay I, Hecht SM..  (2017)  Influence of substituent heteroatoms on the cytoprotective properties of pyrimidinol antioxidants.,  25  (5): [PMID:28189395] [10.1016/j.bmc.2017.01.030]

Source